A study which shows the ability to process information declines as average blood sugar levels increase in people with Type 2 Diabetes is further proof that inadequate blood glucose control is associated with poor memory function, it has been claimed.

Research conducted at Wake Forest University Baptist Medical Center, US, which appears in this month's issue of Diabetes Care discovered an inverse relationship between average blood glucose levels over a two-to-three month time-frame and cognitive test scores.

According to principal investigator Dr Jeff Williamson, this suggests that poor memory function can be identified in patients before it develops into more acute memory loss.

Dr Williamson also stressed that steps need to be taken to ensure diabetes patients fully understand the consequences of their condition.

"People with Type 2 Diabetes and their health care providers need to be careful in situations where there is education and teaching about diabetes care, as patients may need a little more time to absorb and process information," he commented.

"Patients also need to be open to having a family member periodically making sure they are keeping track of managing their diabetes through monitoring, diet, exercise and medication."

More than two million people have diabetes in the UK alone.

Login and visit the Diabetes Knowledge Centre

• Drug combination lowers risk of kidney disease 20/02/09
• Porridge could limit type-2 diabetes side effects 09/01/09
• Men with type-2 diabetes at greater risk of cardiovascular death 06/01/09
• Decline in mental processing affects diabetes patients, study reveals 05/01/09
• Leptin study could lead to new diabetes treatment 23/12/08

• PRANDIN Tablets - 49.44%
  ... in patients with type 2 diabetes (Non Insulin-Dependent Diabetes Mellitus (NIDDM)) whose hyperglycaemia can no longer be controlled satisfactorily by diet, weight reduction and exercise. Repaglinide is also indicated in combination with metformin in type 2 diabetes patients who are not ...
  
  
• DDAVP - 49.42%
  ... and treatment of vasopressin-sensitive cranial diabetes insipidus; establishing renal concentration capacity. DDAVP Tablets: Treatment of vasopressin-sensitive cranial diabetes insipidus; treatment of post-hypophysectomy polyuria/ polydipsia. DDAVP/Desmopressin Injection: Cranial diabetes insipidus ...
  
  
• JANUVIA Film-Coated Tablets - 47.95%
  JANUVIA is indicated in patients with type 2 diabetes mellitus to improve glycaemic control in combination with metformin when diet and exercise, plus metformin do not provide adequate glycaemic control. For patients with type 2 diabetes mellitus in whom use of a PPAR? agonist (i.e. a ...
  
  
• EXUBERA - 47.95%
  ... for the treatment of adult patients with type 2 diabetes mellitus not adequately controlled with oral antidiabetic agents and requiring insulin therapy. EXUBERA is also indicated for the treatment of adult patients with type 1 diabetes mellitus, in addition to long or intermediate acting ...
  
  
• HUMALOG - 47.95%
  For the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. HUMALOG, HUMALOG Pen or HUMALOG KwikPen is also indicated for the initial stabilisation of diabetes mellitus ...
  
  
• Chlorpropamide - 47.95%
  Diabetes mellitus. Diabetes insipidus ...